Matrix Asset Management

EmerGeo provides emergency and crisis management software and services to clients worldwide. In response to growing demands for multi-agency interoperability and real-time situational awareness, EmerGeo has developed two integrated products: Fusionpoint and EmerGeo Mapping. The company has deployed its software to government and industry clients across North America, Australia and the Middle East. For current investment opportunities in this rapidly growing global industry, please contact Mike Morrow at mmorrow@emergeo.com.

Morega Systems Inc. is a software and consumer product company with advanced media mobility solutions for the digital home. Utilizing advanced transcoding, transcrypting and QoS aware streaming capabilities, Morega provides a complete solution for premium service operators and hardware vendors with high value applications such as side-loading, place-shifting and targeted ad insertion. Morega is dedicated to creating rich, new, media experiences for consumers through the introduction of innovative consumer products, software and applications that enable seamless content mobility for both premium and personal media content.

Blueprint provides industry-leading software solutions that help large organizations build better business applications. Our products – Blueprint Storyteller and Blueprint Regulatory Compliance Manager – resolve many of the time-consuming, costly, and error- prone functions that challenge IT organizations. Our products sit at the front of the toolchain, ensuring alignment of business and IT stakeholders. We’ve created closed loop solutions that drive innovation and collaboration, ensure regulatory compliance, and protect the business value of products from definition to delivery. More than half of all Fortune 100 companies across the globe have chosen Blueprint to automate their most complex digital transformation challenges. For more information, please visit http://www.blueprintsys.com/.

Valocor Therapeutics, Inc., a clinical stage biotech company, develops new therapies to treat dermatological conditions with unmet medical needs. Its products include Lemuteporfin, a potent and selective topical photodynamic therapy approach to sebaceous gland targeting for severe acne; VAL-001, a topical sebum inhibitor targeting acne and sebaceous gland hyperactivity; VAL-002, a small-molecule kinase-inhibitor for topical treatment of chronic inflammatory skin diseases; and VAL-003, a Kinase inhibitor with dual melanin-stimulating and immune-modulating activities. Valocor Therapeutics, Inc. was founded in 2008 and is based in Vancouver, Canada.